[1]
Morales A, M. et al. 2024. NLRP3 inflammasome as a therapeutic target in cardiovascular diseases: An update of preclinical and clinical evidence. Journal of International Crisis and Risk Communication Research . (Jun. 2024), 1361–1377. DOI:https://doi.org/10.63278/jicrcr.vi.2246.